Canada defeats NAFTA claim over pharma patents
Canada has defeated a US$374 million NAFTA claim brought by US drugmaker Eli Lilly over the revocation of two drug patents.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.